Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02335814
Title First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Flexus Biosciences, Inc.
Indications

acute myeloid leukemia

Therapies

FLX925

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST